Preventive Nephrology: A Time for Action

Abstract

The incidence of new end-stage renal failure (ESRF) treated with dialysis in Singapore has risen from 96 per million population (pmp) in 1992 to 167 pmp in 2000.1,2 This near-doubling is not unique to Singapore, and many other Asian countries have seen a similar increase in the incidence of ESRF, in large part due to an increasing incidence of the risk factors for renal disease. Consequent to this high incidence of ESRF, at the end of 2002, an estimated 301,649 patients were on dialysis in Asia.3